Page 38 - Read Online

Page 12 of 13 Udukala et al. J Cancer Metastasis Treat 2020;6:25 I http://dx.doi.org/10.20517/2394-4722.2020.45

Copyright
© The Author(s) 2020.

REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30.
2. Kay FU, Kandathil A, Batra K, Saboo SS, Abbara S, et al. Revisions to the Tumor, Node, Metastasis staging of lung cancer (8(th)
edition): Rationale, radiologic findings and clinical implications. World J Radiol 2017;9:269-79.
3. American Cancer Society. Be Inspired by the Words and Music of Hope. Available from: https://www.cancer.org/cancer/lung-cancer/
detection-diagnosis-staging/staging-nsclc.html. [Last accessed on 20 Jul 2020]
4. Wang H, Udukala DN, Samarakoon TN, Basel MT, Kalita M, et al. Nanoplatforms for highly sensitive fluorescence detection of cancer-
related proteases. Photochem Photobiol Sci 2014;13:231-40.
5. Udukala DN, Wang H, Wendel SO, Malalasekera AP, Samarakoon TN, et al. Early breast cancer screening using iron/iron oxide-based
nanoplatforms with sub-femtomolar limits of detection. Beilstein J Nanotechnol 2016;7:364-73.
6. Voelz BE, Kalubowilage M, Bossmann SH, Troyer DL, Chebel RC, et al. Associations between activity of arginase or matrix
metalloproteinase-8 (MMP-8) and metritis in periparturient dairy cattle. Theriogenology 2017;97:83-8.
7. Kalubowilage M, Covarrubias-Zambrano O, Malalasekera AP, Wendel SO, Wang H, et al. Early detection of pancreatic cancers in liquid
biopsies by ultrasensitive fluorescence nanobiosensors. Nanomedicine 2018;14:1823-32.
8. Callsearch. Homepage. Available from: https://www.cellsearchctc.com/. [Last accessed on 20 Jul 2020]
®
9. The cobas EGFR Mutation Test v.2. Available from: http://www.cobasegfrtest.com/. [Last accessed on 20 Jul 2020]
10. Bossmann SH. Liquid Biopsies for Early Cancer Detection. In: Park K, editor. Biomaterials for Cancer Therapeutics, 2nd Edition,
Evolution and innovation. Amsterdam: Elsevier; 2020. pp. 233-59.
11. Available from: http://www.personalgenome.com/. [Last accessed on 24 Jul 2020]
12. Available from: http://www.genomichealth.com/. [Last accessed on 24 Jul 2020]
13. Available from: https://www.myriad.com/. [Last accessed on 24 Jul 2020]
14. Available from: https://www.guardanthealth.com/. [Last accessed on 24 Jul 2020]
15. Available from: https://www.pathway.com/. [Last accessed on 24 Jul 2020]
16. Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood
test. Science 2018;359:926-30.
17. Lennon AM, Buchanan AH, Kinde I, Warren A, Honushefsky A. Feasibility of blood testing combined with PET-CT to screen for cancer
and guide intervention. Science 2020;369;eabb9601.
18. Locke WJ, Guanzon D, Ma C, Liew YJ, Duesing KR, et al. DNA methylation cancer biomarkers: translation to the clinic. Front Genet
2019;10:1150.
19. Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, et al. Sensitive and specific multi-cancer detection and localization using
methylation signatures in cell-free DNA. Ann Oncol 2020;31:745-59.
20. auf dem Keller U, Doucet A, Overall CM. Protease research in the era of systems biology. Biol Chem 2007;388:1159-62.
21. Langer F, Bokemeyer C. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis
with focus on tissue factor. Hamostaseologie 2012;32:95-104.
22. Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol 2011;21:228-37.
23. Merchant N, Nagaraju GP, Rajitha B, Lammata S, Jella KK, et al. Matrix metalloproteinases: their functional role in lung cancer.
Carcinogenesis 2017;38:766-80.
24. Kayser K, Richter N, Hufnagl P, Kayser G, Kos J, et al. Expression, proliferation activity and clinical significance of cathepsin B and
cathepsin L in operated lung cancer. Anticancer Res 2003;23:2767-72.
25. Werle B, Kotzsch M, Lah TT, Kos J, Gabrijelcic-Geiger D, et al. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and
plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer. Anticancer Res 2004;24:4147-61.
26. Terasawa Y, Hotani T, Katayama Y, Tachibana M, Mizuguchi H, et al. Activity levels of cathepsins B and L in tumor cells are a biomarker
for efficacy of reovirus-mediated tumor cell killing. Cancer Gene Ther 2015;22:188-97.
27. Basel MT, Bosssmann SH, Troyer DL, inventors; Kansas State Research Foundation, assignee. Protease Assay. USA patent 8969027;
9682155; 9731034. 2015 Mar 15; 2017 Jun 20; 2017 Aug 15.
28. Basel MT, Bosssmann SH, Troyer DL, inventors; Kansas State Research Foundation, assignee. Protease Assay. Canada patent 8969027;
9682155; 9731034. 2017 Feb 28.
29. Basel MT, Bosssmann SH, Troyer DL, inventors; Kansas State Research Foundation, assignee. Protease Assay. United Kingdom patent
8969027; 9682155; 9731034. 2014 Sep 17.
30. Das P, Sedighi A, Krull UJ. Cancer biomarker determination by resonance energy transfer using functional fluorescent nanoprobes. Anal
Chim Acta 2018;1041:1-24.
31. Craik CS, Page MJ, Madison EL. Proteases as therapeutics. Biochem J 2011;435:1-16.
32. MEROPS release 12.2. Available from: https://www.ebi.ac.uk/merops/. [Last accessed on 20 Jul 2020]
33. Welch BL. The generalization of student’s problem when several different population variances are involved. Biometrika 1947;34:28-35.
34. Coffey CS, Cofield SS. Parametric linear models. Biostatistics 2006;15:223-43.
35. Page RB, Stromberg AJ. Linear methods for analysis and quality control of relative expression ratios from quantitative real-time